Columbia, MO6 Active Studies

Ankylosing Spondylitis Clinical Trials in Columbia, MO

Find 6 actively recruiting ankylosing spondylitis clinical trials in Columbia, MO. Connect with local research sites and explore new treatment options.

6
Active Trials
5
Sponsors
3,960
Enrolling

Recruiting Ankylosing Spondylitis Studies in Columbia

NCT07052942Recruiting

Individualizing Treatment for Asthma in Primary Care (Full Study)

While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foun...

Columbia, MOPHASE43,200 participantsDARTNet Institute
View Study Details
NCT06212947Recruiting

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest....

Columbia, MO400 participantsBioMarin Pharmaceutical
View Study Details
NCT06410976Recruiting

Prospective Clinical Assessment Study in Children With Hypochondroplasia

This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH)....

Columbia, MO150 participantsQED Therapeutics, a BridgeBio company
View Study Details
NCT04742894Recruiting

Neural Bases of Vocal Sensorimotor Impairment in Aphasia

Aphasia is the most common type of post-stroke communication disorder characterized by deficits in speech comprehension, production and control. While recovery can be promoted with speech therapy, imp...

Columbia, MONA100 participantsThe University of Texas at Dallas
View Study Details
NCT07126262Recruiting

A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

The purpose of this study is to evaluate the safety and efficacy of daily administration of vosoritide in participants with HCH aged 0 to \< 36 months over a 52-week period....

Columbia, MOPHASE260 participantsBioMarin Pharmaceutical
View Study Details
NCT04234386Recruiting

GammaPod Dose Escalation Radiation for Early Stage Breast Cancer

The GammaPod machine was made by Xcision Medical Systems and is already FDA cleared to deliver focused radiation within the breast. Unlike current radiation machines, the GammaPod was designed specifi...

Columbia, MONA50 participantsUniversity of Maryland, Baltimore
View Study Details

About Ankylosing Spondylitis Clinical Trials in Columbia

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 6 ankylosing spondylitis clinical trials recruiting participants in Columbia, MO. These studies are seeking a combined 3,960 participants. Research is being sponsored by DARTNet Institute, BioMarin Pharmaceutical, QED Therapeutics, a BridgeBio company and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Columbia — FAQ

Are there ankylosing spondylitis clinical trials in Columbia?

Yes, there are 6 ankylosing spondylitis clinical trials currently recruiting in Columbia, MO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Columbia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbia research site will contact you about next steps.

Are clinical trials in Columbia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbia studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 6 active trials in Columbia are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated September 2, 2026 from ClinicalTrials.gov